Sham Foam's SME IPO concluded with 2.32 times subscription, raising Rs 40.48 crore. While the company reported strong profit growth in FY26, investors should consider risks such as ongoing trademark litigation, reliance on a single manufacturing facility, and working capital intensity.
Sham Foam, a manufacturer of polyurethane foam and mattresses, concluded its initial public offering on August 13, 2026. The company successfully raised Rs 40.48 crore by issuing shares at a fixed price of Rs 130 each. The offering was subscribed 2.32 times overall, with retail investors showing active participation by subscribing 2.61 times their allocated quota, reflecting interest in the company’s maiden public listing.
The net proceeds from the IPO are primarily designated to support the company’s growth and operational needs. Approximately Rs 14.7 crore is planned for civil construction and the acquisition of new machinery for its manufacturing facility in Ambala, Haryana. Another Rs 14.25 crore will be directed toward working capital requirements to support daily operations. The company’s recent financial data shows a strong upward trend, with net profit rising to Rs 8.65 crore for the fiscal year ended March 2026, compared to Rs 3.58 crore in the previous year, while revenue grew to Rs 92.3 crore.
However, potential investors should carefully weigh several risks associated with the business. One significant factor is the ongoing trademark infringement litigation initiated by Sheela Foam Limited regarding the company's 'FEATHER FRESH' brand. The outcome of this legal matter remains a key monitorable. Furthermore, the company faces geographic concentration risk, as it relies on a single manufacturing unit in Ambala which operates on leased premises. Any disruption at this location could impact production capacity.
The business is also sensitive to the volatility of raw material prices, which make up a substantial portion of its total revenue, and it deals with a high working capital cycle, with trade receivables currently standing at around 93 days. With a debt-to-equity ratio of 0.19x, the company maintains relatively low leverage, but the sustainability of its sharp profit increase will be important for future performance evaluation.
The share allotment process is expected to be finalized on August 14, 2026. The company’s stock is scheduled to list on the BSE SME platform on August 18, 2026. Investors should track the company’s management commentary on the legal case and their ability to efficiently manage working capital as it deploys the new capital.